Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Lease liabilities | (9,290) | (10,908) |
| Net cash used in operating activities | (187,048) | (208,375) |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (302) | (4,982) |
| Purchase of an intangible asset | (1,995) | (2,158) |
| Decrease in cash related to disposal of a business | — | (4,438) |
| Purchases of investments | — | (1,500) |
| Net cash used in investing activities | (2,297) | (13,078) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s capex?
- Recursion Pharmaceuticals, Inc. (RXRX) reported capex of $44K in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s capex changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s capex decreased by 98.6% year-over-year, from $3.15M to $44K.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s capex?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s capex has grown at a -36.5% compound annual growth rate (CAGR), from $39.8M to $6.47M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Recursion Pharmaceuticals, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude